- Telehealth Visits
- Insurance plan information
Victoria Chang, MD
She | Her | HersMovement Disorders Neurology • Neurology- Telehealth Visits
- Insurance plan information
Victoria Chang, MD
She | Her | HersMovement Disorders Neurology • Neurology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Victoria Chang is a neurologist who cares for patients with a variety of movement disorders including Parkinson’s disease, essential tremor, dystonia, ataxia and functional neurologic disorder. She has special expertise in using deep brain stimulation devices to treat movement issues associated with Parkinson's disease and botulinum toxin therapy for dystonia and spasticity.
Chang is involved in studies of promising gene and cell-based treatments for Parkinson's disease.
Chang earned her medical degree from the University of California San Diego School of Medicine. She completed a residency in neurology at the University of Washington School of Medicine and a fellowship in movement disorders at UCSF.
Outside of work, Chang enjoys hiking, backpacking, weightlifting and improving her Mandarin and Hindi.
Education & training
Board certification
- Neurology, American Board of Psychiatry/Neurology-Neurology
Fellowship
- Movement Disorders, UCSF Graduate Medical Education
Residency
- Neurology, University of Washington School of Medicine
Internship
- Internal Medicine, University of Washington School of Medicine
Degree
- MD, University of California San Diego School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224650%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224650%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.